IA Trial Radar | ||
|---|---|---|
L'essai clinique NCT01805245 pour Détresse émotionnelle, Diabète de type 2, Stress est terminé. Consultez la vue en carte du Radar des Essais Cliniques et les outils de découverte par IA pour tous les détails, ou posez vos questions ici. | ||
Un essai clinique correspond aux filtres sélectionnés
Vue en carte
Mindfulness: a Novel Approach for the Management of Diabetes-related Distress 78 Randomisé Novateur
Les détails de l'essai clinique sont principalement disponibles en anglais. Cependant, l'IA Trial Radar peut vous aider ! Cliquez simplement sur 'Expliquer l'étude' pour voir et discuter des informations sur l'étude dans la langue sélectionnée.
L'essai clinique NCT01805245 a été une étude interventionnel pour Détresse émotionnelle, Diabète de type 2, Stress. Son statut actuel est : terminé. L'étude a commencé le 1 janvier 2012, avec un objectif de recruter 78 participants. Dirigée par l'Université de Caroline du Nord à Chapel Hill, l'étude s'est terminée le 1 décembre 2015. Les données du site ClinicalTrials.gov ont été mises à jour pour la dernière fois le 19 avril 2017.
Résumé succinct
The purpose of this study is to evaluate the impact of stress reduction on physiological and psychological variables in adults with Type 2 diabetes (T2DM) who have moderate to severe levels of diabetes-related emotional distress. Subjects will be randomized to one of two interventions. We will evaluate the impact of the interventions on glucose metabolism, blood pressure, diabetes-related distress and quality of life...Afficher plus
Titre officiel
Mindfulness: a Novel Approach for the Management of Diabetes-related Distress
Pathologies
Détresse émotionnelleDiabète de type 2StressAutres identifiants de l'étude
- 11-0333
Numéro NCT
Date de début (réel)
2012-01
Dernière mise à jour publiée
2017-04-19
Date de fin (estimée)
2015-12
Inscription (estimée)
78
Type d'étude
Interventionnel
PHASE
N/A
Statut
Terminé
Objectif principal
Traitement
Méthode d'allocation
Randomisé
Modèle d'intervention
Parallèle
Masquage
Simple aveugle
Bras / Interventions
| Groupe de participants/Bras | Intervention/Traitement |
|---|---|
ExpérimentalMindfulness Based Stress Reduction | Réduction du stress basée sur la pleine conscience Standard 8-week MBSR program; classes meet for 2.5 hours once weekly The health education control group meets at the same time and for the same amount of time |
Comparateur actifHealth Education Control | Réduction du stress basée sur la pleine conscience Standard 8-week MBSR program; classes meet for 2.5 hours once weekly The health education control group meets at the same time and for the same amount of time |
Critère principal d'évaluation
Critère secondaire d'évaluation
| Critères d'évaluation | Description de la mesure | Période |
|---|---|---|
HgA1c | We will assess change in glycemic control using the A1c. It will be measured at baseline, immediately following the 8 week intervention and at 24 weeks from baseline. | 0,8,24 weeks |
Diabetes Distress | The Problem Areas in Diabetes will be used to assess the change in diabetes emotional distress at baseline, immediately following the 8 week intervention and at 24 weeks from baseline | 0,8,24 weeks |
| Critères d'évaluation | Description de la mesure | Période |
|---|---|---|
SF36 Physical Health Score | This measure is a patient reported outcome assessing general quality of life and will be assessed using the standardized SF36 tool. | 0, 8,24 weeks |
SF36 Mental Health Score | This measure is a patient reported outcome assessing general quality of life and will be assessed using the standardized SF36 tool. | 0,8,24 weeks |
Mean 24 hour ambulatory systolic blood pressure | Mean systolic blood pressure over 24 hours. | 0,8,24 weeks |
Mean 24 hour diastolic ambulatory blood pressure | Mean diastolic blood pressure over 24 hours | 0,8,24 weeks |
HOMA-IR | For those participants that are not using insulin, we will assess the degree of insulin resistance using the HOMA-IR, which is derived from the fasting insulin and fasting glucose. | 0,8,24 weeks |
Depression | Using the Beck Depression Inventory we will assess symptoms of depression using this standardized patient reported outcome. | 0,8,24 weeks |
State Anxiety | Using the State and Trait Anxiety Assessment we will measure "state" anxiety. | 0,8,24 weeks |
Trait Anxiety | Using the State and Trait Anxiety Survey we will assess "trait" anxiety. | 0,8,24 weeks |
Social Support | Using the Duke Social Support and Stress Scale we will assess the degree of social support participants report in their lives. | 0,8,24 weeks |
Coping Style | Using the Coping Orientation to Problems Experienced Scale, we will evaluate the various coping styles and how they may change over time. | 0,8,24 weeks |
General Stress | Using the Perceived Stress Scale we will assess general life stressors. | 0,8,24 weeks |
Cortisol 24 hour area under the curve | Calculating the area under the curve for 24 hours we will assess cortisol secretion as a physiological assessment of stress | 0,8,24 weeks |
Cortisol Awakening Response | We will measure the cortisol awakening response using measures of cortisol prior to arising and 30 minutes after waking up. | 0,8,24 weeks |
IL-6 | IL-6 is an assessment of systemic inflammation and will be measured in serum. | 0,8, 24 weeks |
Summary of Diabetes Self-Care Activities | This patient reported measure assesses the frequency which participants engage in self-care activities that are critical for DM self-management. | 0,8,24 weeks |
Average 24 hour glucose by continuous glucose monitor (cgm) | Average cgm glucose over 24 hours | 0,8,24 weeks |
Average night time glucose | Average night time glucose from 10pm-6am using continuous glucose monitoring values | 0,8,24 weeks |
Average day time glucose | Average day time glucose from 6am-10pm using continuous glucose monitoring values | 0,8,24 weeks |
Block Food Frequency Questionnaire | Standardized assessment of dietary patterns | Week 0 |
Mean Day Systolic Ambulatory Blood Pressure | The average systolic blood pressure measured by ambulatory blood pressure monitoring between 6 am and 10 pm | 0,8,24 weeks |
Mean Day Diastolic Ambulatory Blood Pressure | The average systolic blood pressure measured by ambulatory blood pressure monitoring between 6 am and 10 pm | 0,8,24 weeks |
Mean Night Systolic Ambulatory Blood Pressure | The average systolic blood pressure measured by ambulatory blood pressure monitoring between 10 pm and 6 am. | 0,8,24 weeks |
Mean Night Diastolic Ambulatory Blood Pressure | The average diastolic blood pressure measured by ambulatory blood pressure monitoring between 10 pm and 6 am. | 0,8,24 weeks |
Critères d'éligibilité
Âges éligibles
Adulte, Adulte âgé
Âge minimum
30 Years
Sexes éligibles
Tous
Age > 30 years
Male or female
Duration of diabetes 1-15 years from time of initial diagnosis
Diagnosis of T2DM made/confirmed by physician
Completed diabetes education in the past
Most recent HgA1c >7%; measurement must be within the past 6 months either in physicians office or at the Thriving with Diabetes Boot Camp Class
Treatment for diabetes must include any or all of the following modalities:
diet, exercise, oral medications, insulin or other injectable diabetic medication
Score > 30 on the Problem Area in Diabetes (PAID) Questionnaire
Able to use a glucometer for self-monitoring of blood glucose values
Most recent clinic blood pressure less than 180/95
- History of ketoacidosis
- Age at diagnosis of T2DM < 30 years
- Score >15 on the PHQ-9
- Previous training in relaxation or meditation techniques
- Current practice of yoga, tai chi or any other mind-body movement for > 60 minutes per week
- Current use of a psychoactive drug for less than 3 months or not yet on a stable dose
- Inability to participate fully or behave appropriately in the group treatment setting, as observed by baseline acknowledgement of substance abuse, psychotic episode(s), psychiatric hospitalization or history of self- harm within the past 2 years, or current suicidal or homicidal ideation
- Inability to complete standardized instruments because of a cognitive deficit or language barrier
- Current use or use within the past 3 months of oral glucocorticoids, excluding intraocular, topical or inhaled preparations
- History of inflammatory diseases including rheumatoid arthritis and inflammatory bowel disease
- Use of immune modulating agents
- Night shift work or other type of schedule in which sleep wake cycle is disrupted
- Women who consume > 7 alcoholic drinks per week and men who consume > 14 drinks per week
- Current use or history of daily tobacco use within the past 1 year
- End stage renal failure on dialysis
- Pregnancy or post partum <3 months
- Subjects with known secondary causes of hypertension including renal artery stenosis, pheochromocytoma, coarctation of aorta, hyperaldosteronemia
- Non-dominant arm circumference > 46cm
- Unwilling to accept randomization
Aucune donnée de contact disponible
1 Centres de l'étude dans 1 pays
North Carolina
University of North Carolina, Chapel Hill, North Carolina, 27599, United States